Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...
As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...
New Delhi, The Delhi High Court on Tuesday ordered auctioning of the Fortis trademark in connection with the ₹3,500 crore arbitral award passed in favour of Japanese pharma major Daiichi Sankyo ...
Shares in Esperion Therapeutics lost more than half of their value after it disclosed a dispute with Daiichi Sankyo on a $300 million milestone payment relating to cholesterol drug Nexletol.
Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...
The campaign is presented by Daiichi-Sankyo and AstraZeneca, while Merck serves as a gold-level sponsor and Eli Lilly, Pfizer and Guardant come aboard as community sponsors. In the campaign’s ...
WWE Superstar Shinsuke Nakamura announced this morning that he is officially returning to Pro Wrestling NOAH for another match against Ulka Sasaki. With an extended working relationship with TNA ...
A DAIICHI representative stated, "Indonesia is one of the countries with the most islands in the world, and since travel is a part of daily life, there are many families traveling with children.
On Saturday, October 19, 2024, the official staff for Go For It, Nakamura! anime shared a new promotional video and visual to confirm the show's 2025 release window. Along with the announcement ...
Back in 2011, the world held its breath after the Fukushima Daiichi nuclear plant in Japan suffered a failure of its cooling systems, in the wake of the country getting hit by a 9.0 magnitude ...
The WWE Universe has eagerly anticipated the push of Shinsuke Nakamura. After much success, things seemingly stalled for the Japanese superstar over the last year or so, and his future has been a ...